Navigation Links
A new spin on drug delivery
Date:7/9/2010

Blacksburg, Va., July 12, 2010 Chang Lu and his chemical engineering research group at Virginia Tech have discovered how to "greatly enhance" the delivery of DNA payloads into cells. The description of their work will be featured on the cover of Lab on a Chip (issue 16), the premier journal for researchers in microfluidics. http://www.rsc.org/Publishing/Journals/LC/article.asp?doi=c004472e

The work also appears in the July 8 issue of Nature magazine (Vol. 466, p. 163) http://www.nature.com/nature/journal/v466/n7303/pdf/466163d.pdf

Lu's ultimate goal is to apply this technique to create genetically modified cells for cancer immunotherapy, stem cell therapy and tissue regeneration.

One of the most widely used physical methods to deliver genes into cells "is incredibly inefficient because only a small fraction of a cell's total membrane surface can be permeated," said Lu, an associate professor of chemical engineering at Virginia Tech. http://www.microfluidics.che.vt.edu/

The method Lu is referring to is called electroporation, a phenomenon known for decades that increases the permeability of a cell by applying an electric field to generate tiny pores in the membrane of cells.

Lu called the process "a new spin on DNA delivery." He explained the process saying, "Conventional electroporation methods deliver DNA only within a very small portion of the cell surface, determined by the physics governing the interaction between an electric field and a cell. Our method enables uniform DNA delivery over the entire cell surface, which is the first time we are aware that this has been demonstrated. The result is a greatly enhanced transfer of the genetic material."

Lu said his new approach harnesses "hydrodynamic effects that uniquely occur when fluids flow along curved paths. Flow under these conditions is known to generate vortices. Cells carried by such flow experience rotation and spinning that help expose the majority area of its surface to the electric field. " Having the gene delivery done by flows in curved paths is key in the gene delivery as opposed to the traditionally used, electroporation in static solution or in straight channels. "A spiral-shaped channel design yields a two-fold increase than a straight channel and an even larger factor compared to in static solution," he added.

By using fluorescence microscopy, they were able to "map" the area on the cell surface that was subjected to electroporation, and determine the extent of the DNA entry into the cell.

Lu explained the conventional delivery using a cuvette-type of device with static cell suspension produces DNA delivery confined to a narrow zone on the cell surface. However, when electroporation is applied to flowing cells in a spiral or curved channel , the images "appear dramatically different with the DNA delivery uniformly distributed over the entire cell surface."


'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert  

Related biology news :

1. Researchers develop drug delivery system using nanoparticles triggered by electromagnetic field
2. Geisinger Implements MedEx System to Enhance Medication Delivery, Tracking
3. Air pollution doesnt increase risk of preeclampsia, early delivery, study finds
4. Importance of insulin delivery devices for diabetes management
5. Multistage nanovector system provides sustained delivery of siRNA cancer therapeutic in mice
6. ViroPharma Announces Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze(TM) (C1 Esterase Inhibitor [Human])
7. Phoenix Solar AG and MiaSole Sign Multi-Year Framework Agreement for the Delivery of Thin-Film Solar Modules
8. Pitt-led international study identifies human enzyme that breaks down potentially toxic nanomaterials, opens door to novel drug delivery
9. Cancer therapy using unique imaging, delivery system focus of NSF CAREER Award
10. UC-developed technology to assist research and genetic drug delivery
11. Lower income women report more insurance-based discrimination during pregnancy, delivery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A new spin on drug delivery
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Florida , February 16, 2017 ... with the infusion of innovative telemedicine application, new ... services that are experiencing a boom worldwide. The ... the advancement of technologies, services and new therapies ... (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced today the ... Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial ... physician suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative ...
(Date:2/16/2017)... 16, 2017  Rhythm, a biopharmaceutical company ... that result in life-threatening metabolic disorders, today ... mezzanine round of financing with existing investors ... New Enterprise Associates, Pfizer Venture Investments, Third ... investment fund. Rhythm will use the proceeds ...
Breaking Biology Technology: